Neola Medical AB Cash Flow-to-Debt Ratio
Neola Medical AB cash flow-to-debt ratio. Neola Medical AB (NEOLA) has a Cash Flow-to-Debt Ratio of -0.36x as of June 2026, meaning its operating cash flow of Skr-2.48 Million could theoretically repay 0% of its total liabilities (Skr6.86 Million) in one year. See NEOLA FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Neola Medical AB (2018–2025)
Cash flow-to-debt ratio of Neola Medical AB from 2018 to 2025. Historical debt coverage capacity for Neola Medical AB across 8 annual periods. Check NEOLA cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Neola Medical AB Cash Flow-to-Debt Ratio by Year (2018–2025)
Neola Medical AB cash flow-to-debt ratio by year from 2018 to 2025. Year-by-year debt coverage analysis for Neola Medical AB. For the full cash flow conversion analysis, see Neola Medical AB (NEOLA) cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (SEK) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -3.99x | Skr-11.95 Million | Skr3.00 Million | ▼ -71.0% |
| 2024 | -2.33x | Skr-10.84 Million | Skr4.65 Million | ▼ -149.1% |
| 2023 | -0.94x | Skr-6.54 Million | Skr6.99 Million | ▲ +13.6% |
| 2022 | -1.08x | Skr-8.50 Million | Skr7.84 Million | ▲ +50.1% |
| 2021 | -2.17x | Skr-6.93 Million | Skr3.19 Million | ▲ +13.6% |
| 2020 | -2.51x | Skr-6.08 Million | Skr2.42 Million | ▼ -82.4% |
| 2019 | -1.38x | Skr-2.07 Million | Skr1.50 Million | ▲ +30.0% |
| 2018 | -1.97x | Skr-1.32 Million | Skr671.00K | — |